SCHEMBL160811

SCHEMBL160811

CCCCCC(O)C=Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.47
DDAH1 O94760 1/20 0.47
GAPDH P04406 1/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.45
EGFR P00533 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
CSNK1E P49674 1/20 0.43
LTB4R Q15722 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
RECQL P46063 1/20 0.41
HIF1A Q16665 1/20 0.41
HDAC3 O15379 1/20 0.41
PTGER4 P35408 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301113 1.00 TRPA1 (0.47) TRPA1DDAH1GAPDHMAPTLMNA
SCHEMBL27642615 0.98 EGFR (0.47) TRPA1DDAH1GAPDHMAPTLMNA
SCHEMBL6897132 0.87 MEN1 (0.42) TDP1HDAC3
SCHEMBL6897130 0.87 MEN1 (0.42) TDP1HDAC3
SCHEMBL300790 0.86 LMNA (0.45) TRPA1DDAH1GAPDHMAPTLMNA
Pyruvate SCHEMBL28628122 0.86 ACHE (0.49) LMNAEGFRTDP1LTB4RHDAC3
SCHEMBL12055605 0.85 CSNK1E (0.47) LMNAEGFRTDP1CSNK1EHDAC3
SCHEMBL28880268 0.83 HTR2A (0.40) MAPTALDH1A1POLB
SCHEMBL23357393 0.82 CYP1A2 (0.41) MAPTLMNAALDH1A1RECQLHDAC3
SCHEMBL9111068 0.81 EGFR (0.43) MAPTLMNAEGFRTDP1CSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1007 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119959400-A Method for simultaneously detecting 24 main fragrances in cosmetics 湖北省普林标准技术服务有限公司 2025-05-09 CN claimed
EP-4208063-B1 DISPENSING PACKAGE AND METHOD FOR CONTROLLED DELIVERY OF A VISCOUS COMPOSITION PROCTER & GAMBLE (US) 2024-12-11 EP claimed
CN-115670525-B Reaction solution for screening hypersensitive sensitive muscles 广州市华代生物科技有限公司 2024-11-29 CN claimed
EP-4037639-B1 BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT BEIERSDORF AG (DE) 2024-11-06 EP claimed
EP-4037642-B1 NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR PROTECTION AGAINST BLUE LIGHT BEIERSDORF AG (DE) 2024-11-06 EP claimed
CN-118203143-A Yulan Tieguanyin flavored electronic cigarette tobacco tar and electronic cigarette 比亚迪精密制造有限公司 2024-06-18 CN claimed
CN-114829004-B Method for preparing Ni-X-based oxide catalyst and application of Ni-X-based oxide catalyst in transfer hydrogenation 中国科学院青岛生物能源与过程研究所 2024-02-27 CN claimed
CN-115466505-B Silicon PU plastic material 邯郸市爱尚体育科技有限公司 2024-01-12 CN claimed
US-11857056-B2 Dispensing package and method for controlled delivery of a viscous composition THE PROCTER & GAMBLE COMPANY (US) 2024-01-02 US claimed
CN-117288858-A Method for detecting sensitized aromatic agent in children cosmetics based on GC-MS/MS 南京海关轻工产品与儿童用品检测中心 2023-12-26 CN claimed
EP-1882471-A2 Cosmetic preparation containing folic acid and perfume constituents Beiersdorf AG (DE) 2008-01-30 EP claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
EP-1705171-A1 Improved aromachemicals Flexitral, Inc. (US) 2006-09-27 EP claimed
US-20060166857-A1 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes SYMRISE GMBH & CO. KG (DE) 2006-07-27 US claimed
US-20060094640-A1 Aromachemicals FLEXITRAL, INC. 2006-05-04 US claimed
US-20050119156-A1 Aromachemicals FLEXITRAL, INC. 2005-06-02 US claimed
EP-1458666-A1 IMPROVED AROMACHEMICALS Flexitral Inc. (US) 2004-09-22 EP claimed
WO-2003053902-A1 IMPROVED AROMACHEMICALS FLEXITRAL, INC. (US) 2003-07-03 WO claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11857056-B2 Dispensing package and method for controlled delivery of a viscous composition ADRA1D, ADRA1A, USE1 TRPA1 3197/4885DDAH1 1198/4885GAPDH 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.